Cargando…
microRNA‐128‐3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down‐regulating NEK2
Emerging evidence has reported that dysregulation of microRNAs (miRNAs) participated in the development of diverse types of cancers. Our initial microarray‐based analysis identified differentially expressed NEK2 related to breast cancer and predicted the regulatory microRNA‐128‐3p (miR‐128‐3p). Here...
Autores principales: | Chen, Yuanwen, Wu, Nian, Liu, Lei, Dong, Huaying, Liu, Xinao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339185/ https://www.ncbi.nlm.nih.gov/pubmed/32558224 http://dx.doi.org/10.1111/jcmm.15317 |
Ejemplares similares
-
MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers
por: Liu, Hai-Ting, et al.
Publicado: (2015) -
MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1
por: Wu, Lan, et al.
Publicado: (2021) -
MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells
por: Koh, Hyebin, et al.
Publicado: (2017) -
Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE
por: Zhang, Guo-Feng, et al.
Publicado: (2020) -
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway
por: Liu, Tong, et al.
Publicado: (2015)